New Study Questions the Effectiveness of the “Female Viagra” Addyi/Flibanserin

It’s been six months since the Food & Drug Administration gave its blessing to the marketing of Addyi, or Flibanserin, a prescription treatment for sexual dysfunction (low libido)  in premenopausal women. There seems to be a lot of controversy among medical professionals about the effectiveness of this new drug. According to a new study published in February …

New Study Questions the Effectiveness of the “Female Viagra” Addyi/Flibanserin Read More »